Data are lacking on whether patients with systemic autoimmune rheumatic diseases (SARDs) experience more severe complications from COVID-19 infection than the general population. To shed light in this area, researchers conducted a matched cohort study of COVID-19 infection outcomes of patients with SARDs from a network of real-time electronic health records data on more than 52 million patients across 32 healthcare organizations between January 20 and June 1. Patients with SARDs were matched 1:1 by age, sex, and race/ethnicity with patients without SARDs. Patients with SARDs had higher rates of comorbidities than comparators, including hypertension, asthma, chronic kidney disease, and heart failure. When compared with those without SARDs, those with SARDs had higher risks of hospitalization (relative risk [RR], 1.23), intensive care unit admission (RR, 1.75), mechanical ventilation (RR, 1.77), acute kidney injury (RR, 1.83), and congestive heart failure (RR, 3.06). Although the mortality rate was numerically higher in patients with SARDs than in comparators, it did not reach statistical significance.
June 14, 2019
May 27, 2020
October 30, 2020
October 5, 2019
- ACC 2020The American College of Cardiology decided to cancel ACC.20/WCC due to COVID-19, which was scheduled to take place March 28-30 in Chicago. However, ACC.20/WCC Virtual Meeting continues to release cutting edge science and practice changing updates for cardiovascular professionals on demand and free through June 2020.
- ENDO: 2020ENDO 2020 Annual Conference has been canceled due to COVID-19. Here are highlights of emerging data that has still been released. Keep an eye out for ENDO Online 2020, which will take place from June 8 to 22.
- CROI 2020Every year, CROI hosts some of the world's leading experts in HIV research, who come to present exciting new data and drive forward the field of HIV/AIDS research. This year, due to COVID-19, CROI held their meeting virtually.